Inflammatory mediators in mastitis and lactation insufficiency

Journal of Mammary Gland Biology and Neoplasia

Volumn 19, Issue 2, 2014, Pages 161-167

  Ingman, Wendy V ^a,b   Glynn, Danielle J ^a,b   Hutchinson, Mark R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Inflammation; Lactation insufficiency; Mastitis; Toll like receptors

Indexed keywords

ALPINETIN; ANTIBIOTIC AGENT; BETA CASEIN; C REACTIVE PROTEIN; CHLOROGENIC ACID; CURCUMIN; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MILK PROTEIN; NITRIC OXIDE; RECEPTOR BLOCKING AGENT; SODIUM; STAT5 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BREAST DUCT; BREAST EPITHELIUM; BREAST FEEDING; CANDIDA ALBICANS; CELL PROLIFERATION; CYTOKINE PRODUCTION; DANGER ASSOCIATED MOLECULAR PATTERN; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ESCHERICHIA COLI; EXCLUSIVE BREAST FEEDING; FEMALE; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INVOLUTION; LACTATION DISORDER; LACTATION INHIBITION; LACTATION INSUFFICIENCY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MASTITIS; MATERNAL STRESS; MEDIATOR RELEASE; MENTAL STRESS; MICROBE ASSOCIATED MOLECULAR PATTERN; MILK PRODUCTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUERPERIUM; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; SYSTEMATIC REVIEW (TOPIC); ANIMAL; BREAST; INFLAMMATION; LACTATION; METABOLISM; PHYSIOLOGY; UDDER;

ANIMALS; BREAST; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LACTATION; LACTATION DISORDERS; MAMMARY GLANDS, ANIMAL; MASTITIS; SIGNAL TRANSDUCTION;

EID: 84905089531     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-014-9325-9     Document Type: Article

References (80)

1. Tang, L., et al., Mastitis in Chinese Breastfeeding Mothers: A Prospective Cohort Study. Breastfeed Med, 2013.
2. Scott JA et al. Occurrence of lactational mastitis and medical management: a prospective cohort study in Glasgow. Int Breastfeed J. 2008;3:21.
3. Kinlay JR, O'Connell DL, Kinlay S. Risk factors for mastitis in breastfeeding women: results of a prospective cohort study. Aust N Z J Public Health. 2001;25(2):115-20.
4. Foxman B et al. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol. 2002;155(2):103-14.
5. Vogel A, Hutchison BL, Mitchell EA. Mastitis in the first year postpartum. Birth. 1999;26(4):218-25.
6. Wambach KA. Lactation mastitis: a descriptive study of the experience. J Hum Lact. 2003;19(1):24-34.
7. Amir LH et al. Incidence of breast abscess in lactating women: report from an Australian cohort. BJOG. 2004;111(12):1378-81.
8. Fetherston C. Characteristics of lactation mastitis in a Western Australian cohort. Breastfeed Rev. 1997;5(2):5-11.
9. Michie C, Lockie F, Lynn W. The challenge of mastitis. Arch Dis Child. 2003;88(9):818-21.
10. Wockel A et al. Inflammatory breast diseases during lactation: health effects on the newborn-a literature review. Mediators Inflamm. 2008;2008:298760.
11. Filteau SM et al. Milk cytokines and subclinical breast inflammation in Tanzanian women: effects of dietary red palm oil or sunflower oil supplementation. Immunology. 1999;97(4):595-600.
12. Morton JA. The clinical usefulness of breast milk sodium in the assessment of lactogenesis. Pediatrics. 1994;93(5):802-6.
13. Aryeetey RN et al. Subclinical mastitis is common among Ghanaian women lactating 3 to 4 months postpartum. J Hum Lact. 2008;24(3):263-7.
14. AIHW, 2010 Australian national infant feeding survey: indicator results. 2011: Cat. no. PHE 156. Australian Institute for Health and Welfare, Canberra.
15. Barkema HW et al. Invited review: The role of contagious disease in udder health. J Dairy Sci. 2009;92(10):4717-29.
16. Osterman KL, Rahm VA. Lactation mastitis: bacterial cultivation of breast milk, symptoms, treatment, and outcome. J Hum Lact. 2000;16(4):297-302.
17. Kvist LJ et al. The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment. Int Breastfeed J. 2008;3:6.
18. Delgado S et al. Staphylococcus epidermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics. BMC Microbiol. 2009;9:82.
19. Carmichael AR, Dixon JM. Is lactation mastitis and shooting breast pain experienced by women during lactation caused by Candida albicans? Breast. 2002;11(1):88-90.
20. Fetherston C. Mastitis in lactating women: physiology or pathology? Breastfeed Rev. 2001;9(1):5-12.
21. Lindberg E et al. Long-time persistence of superantigen-producing Staphylococcus aureus strains in the intestinal microflora of healthy infants. Pediatr Res. 2000;48(6):741-7.
22. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-20.
23. Zdrazilek J. Staphylococcus aureus at a maternity ward. I. Colonization of mothers and neonates and survival of various S. aureus types in colonized individuals. J Hyg Epidemiol Microbiol Immunol. 1988;32(1):49-57.
24. Barbosa-Cesnik C, Schwartz K, Foxman B. Lactation mastitis. JAMA. 2003;289(13):1609-12.
25. Thomsen AC, Espersen T, Maigaard S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol. 1984;149(5):492-5.
26. Thomsen AC, Hansen KB, Moller BR. Leukocyte counts and microbiologic cultivation in the diagnosis of puerperal mastitis. Am J Obstet Gynecol. 1983;146(8):938-41.
27. WHO, Mastitis: causes and management. WHO/FCH/CAH/00, ed. D.o.C.a.A.h.a. Development. 2000, Geneva, Switerzland: World Health Organization.
28. Crepinsek, M.A., et al., Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev, 2012;10: p. CD007239.
29. Jahanfar, S., C.J. Ng, and C.L. Teng, Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev, 2013. 2: p. CD00545.
30. Kvist LJ. Toward a clarification of the concept of mastitis as used in empirical studies of breast inflammation during lactation. J Hum Lact. 2010;26(1):53-9.
31. Fetherston CM, Lai CT, Hartmann PE. Relationships between symptoms and changes in breast physiology during lactation mastitis. Breastfeed Med. 2006;1(3):136-45.
32. Fetherston CM, Wells JI, Hartmann PE. Severity of mastitis symptoms as a predictor of C-reactive protein in milk and blood during lactation. Breastfeed Med. 2006;1(3):127-35.
33. Zheng J, Watson AD, Kerr DE. Genome-wide expression analysis of lipopolysaccharide-induced mastitis in a mouse model. Infect Immun. 2006;74(3):1907-15.
34. Mizuno K et al. Mastitis is Associated with IL-6 Levels and Milk Fat Globule Size in Breast Milk. Journal of Human Lactation. 2012;28(4):529-34.
35. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8(1):49-62.
36. Notebaert S et al. In vivo imaging of NF-kappaB activity during Escherichia coli-induced mammary gland infection. Cell Microbiol. 2008;10(6):1249-58.
37. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol. 2005;17(4):338-44.
38. Sirard JC, Bayardo M, Didierlaurent A. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors. Eur J Immunol. 2006;36(2):260-3.
39. Glynn DJ, Hutchinson MR, Ingman WV. Toll-Like Receptor 4 Regulates Lipopolysaccharide-Induced Inflammation and Lactation Insufficiency in a Mouse Model of Mastitis. Biol Reprod. 2014;90(5):91.
40. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373-84.
41. Gonen E et al. Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cell Microbiol. 2007;9(12):2826-38.
42. Goodridge HS et al. Phosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells. Parasite Immunol. 2007;29(3):127-37.
43. Ichinose T et al. Mouse strain differences in eosinophilic airway inflammation caused by intratracheal instillation of mite allergen and diesel exhaust particles. J Appl Toxicol. 2004;24(1):69-76.
44. Tokunaga Y et al. Genetic susceptibility to the induction of murine experimental autoimmune orchitis (EAO) without adjuvant. I. Comparison of pathology, delayed type hypersensitivity, and antibody. Clin Immunol Immunopathol. 1993;66(3):239-47.
45. Uddin MH et al. Strain variation in the susceptibility and immune response to Clonorchis sinensis infection in mice. Parasitol Int. 2012;61(1):118-23.
46. Elazar S et al. Neutrophil recruitment in endotoxin-induced murine mastitis is strictly dependent on mammary alveolar macrophages. Vet Res. 2010;41(1):10.
47. Chen LC et al. Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia. Exp Mol Pathol. 2007;83(3):311-26.
48. Connelly L et al. Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. J Cell Physiol. 2010;222(1):73-81.
49. Kesaraju P et al. Experimental autoimmune breast failure: a model for lactation insufficiency, postnatal nutritional deprivation, and prophylactic breast cancer vaccination. Am J Pathol. 2012;181(3):775-84.
50. Clarkson RW et al. NF-kappaB inhibits apoptosis in murine mammary epithelia. J Biol Chem. 2000;275(17):12737-42.
51. Geymayer S, Doppler W. Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. FASEB J. 2000;14(9):1159-70.
52. Baxter FO et al. IKKbeta/2 induces TWEAK and apoptosis in mammary epithelial cells. Development. 2006;133(17):3485-94.
53. Zaragoza R et al. Nitric oxide triggers mammary gland involution after weaning: remodelling is delayed but not impaired in mice lacking inducible nitric oxide synthase. Biochem J. 2010;428(3):451-62.
54. O'Brien J et al. Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development. 2012;139(2):269-75.
55. Buchanan MM et al. Toll-like receptor 4 in CNS pathologies. J Neurochem. 2010;114(1):13-27.
56. McDermott MF, Tschopp J. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends Mol Med. 2007;13(9):381-8.
57. Fetherston C. Risk factors for lactation mastitis. J Hum Lact. 1998;14(2):101-9.
58. Abou-Dakn M et al. Inflammatory Breast Diseases during Lactation: Milk Stasis, Puerperal Mastitis, Abscesses of the Breast, and Malignant Tumors - Current and Evidence-Based Strategies for Diagnosis and Therapy. Breast Care (Basel). 2010;5(1):33-7.
59. El Mezayen R et al. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett. 2007;111(1):36-44.
60. Samuvel DJ et al. Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol. 2009;182(4):2476-84.
61. Davis SR et al. Milk L-lactate concentration is increased during mastitis. J Dairy Res. 2004;71(2):175-81.
62. Wockel A et al. Predictors of inflammatory breast diseases during lactation-results of a cohort study. Am J Reprod Immunol. 2010;63(1):28-37.
63. Frank MG, Watkins LR, Maier SF. Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain Behav Immun. 2013;33:1-6.
64. Garate I et al. Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation. 2011;8:151.
65. McCusker RH, Kelley KW. Immune-neural connections: how the immune system's response to infectious agents influences behavior. J Exp Biol. 2013;216(Pt 1):84-98.
66. Hines DJ et al. Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS One. 2013;8(3):e60388.
67. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732-41.
68. Bienkowski MS, Rinaman L. Noradrenergic inputs to the paraventricular hypothalamus contribute to hypothalamic-pituitary-adrenal axis and central Fos activation in rats after acute systemic endotoxin exposure. Neuroscience. 2008;156(4):1093-102.
69. Ringgold KM et al. Prolonged sleep fragmentation of mice exacerbates febrile responses to lipopolysaccharide. J Neurosci Methods. 2013;219(1):104-12.
70. Sharma BS et al. Association of toll-like receptor 4 polymorphisms with somatic cell score and lactation persistency in Holstein bulls. J Dairy Sci. 2006;89(9):3626-35.
71. Wang X et al. Genetic polymorphism of TLR4 gene and correlation with mastitis in cattle. J Genet Genomics. 2007;34(5):406-12.
72. Catalani, E., et al., Short communication: Lymphoproliferative response to lipopolysaccharide and incidence of infections in periparturient dairy cows. J Dairy Sci, 2013.
73. Palm NW, Medzhitov R. Immunostimulatory activity of haptenated proteins. Proc Natl Acad Sci U S A. 2009;106(12):4782-7.
74. Fu Y et al. Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-kappaB signaling pathway in lipopolysaccharide-induced mastitis in mice. Int Immunopharmacol. 2014;20(1):54-8.
75. Ruifeng G et al. Chlorogenic acid attenuates lipopolysaccharide-induced mice mastitis by suppressing TLR4-mediated NF-kappaB signaling pathway. Eur J Pharmacol. 2014;729:54-8.
76. Chen H et al. Alpinetin attenuates inflammatory responses by interfering toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced mastitis in mice. Int Immunopharmacol. 2013;17(1):26-32.
77. WHO. Global strategy for infant and young child feeding. Geneva: World Health Organization; 2003.
78. NHMRC. Infant Feeding Guidelines. Canberra: National Health and Medical Research Council; 2012.
79. Geddes DT, Prescott SL. Developmental origins of health and disease: the role of human milk in preventing disease in the 21 (st) century. J Hum Lact. 2013;29(2):123-7.
80. Black RE et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet. 2008;371(9608):243-60.